A novel SARS-CoV-2 variant, VOC 202012/01 (lineage B.1.1.7), emerged in southeast England in November 2020 and is rapidly spreading toward fixation. Using a variety of statistical and dynamic modelling approaches, we estimate that this variant has a 43–90% (range of 95% credible intervals 38–130%) higher reproduction number than preexisting variants. A fitted two-strain dynamic transmission model shows that VOC 202012/01 will lead to large resurgences of COVID-19 cases. Without stringent control measures, including limited closure of educational institutions and a greatly accelerated vaccine roll-out, COVID-19 hospitalisations and deaths across England in 2021 will exceed those in 2020. Concerningly, VOC 202012/01 has spread globally and exhibits a similar transmission increase (59–74%) in Denmark, Switzerland, and the United States.

The COVID-19 pandemic has shown a markedly low proportion of cases among children 1-4. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. We evaluate these possibilities by fitting an age-structured mathematical model to epidemic data from China, Italy, Japan, Singapore, Canada and South Korea. We estimate that susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12-31%) of infections in 10-to 19-year-olds, rising to 69% (57-82%) of infections in people aged over 70 years. Accordingly, we find that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. Our age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structures-such as many low-income countries-the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic. COVID-19 shows an increased number of cases and a greater risk of severe disease with increasing age 5,6 , a feature shared with the 2003 SARS epidemics 7. This age gradient in reported cases, which has been observed from the earliest stages of the pandemic 1 , could result from children having decreased susceptibility to infection, a lower probability of showing disease on infection or a combination of both, compared with adults. Understanding the role of age in transmission and disease severity is critical for determining the likely impact of social-distancing interventions on SARS-CoV-2 transmission 8 , especially those aimed at schools, and for estimating the expected global disease burden. Here, we disentangle the relative contributions of three potential drivers of the observed distribution of clinical cases by age. We present a summary of the main findings, limitations and implications of this work in Table 1. First, age-varying susceptibility to infection by SARS-CoV-2, where children are less susceptible than adults to becoming infected on contact with an infectious person, would reduce cases among children. Decreased susceptibility could result from immune for predicted global burden and the effectiveness of control interventions. This question must be resolved to effectively forecast and control COVID-19 epidemics.

No abstract

21The COVID-19 pandemic has shown a markedly low proportion of cases among 22 children 1,23,4 . Age disparities in observed cases could be explained by children having lower 23 susceptibility to infection, lower propensity to show clinical symptoms, or both. We evaluate 24 these possibilities by fitting an age-structured mathematical model to epidemic data from six 25 countries. We estimate that clinical symptoms occur in 25% (95% CrI: 19-32%) of infections 26 in 10-19-year-olds, rising to 76% (68-82%) in over-70s, and that susceptibility to infection in 27 under-20s is approximately half that of older adults. Accordingly, we find that interventions 28 aimed at children may have a relatively small impact on total cases, particularly if the 29 transmissibility of subclinical infections is low. The age-specific clinical fraction and 30 susceptibility we have estimated has implications for the expected global burden of COVID-31